Antiinflammatory therapy and Urinary incontinence

Summary:

Urinary incontinence is found among people with Antiinflammatory therapy, especially for people who are female, 60+ old.

The study analyzes which people have Urinary incontinence with Antiinflammatory therapy. It is created by eHealthMe based on reports of 11 people who have Antiinflammatory therapy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Antiinflammatory therapy?

Antiinflammatory therapy is found to be associated with 3 conditions by eHealthMe. Check the latest studies of Antiinflammatory therapy.

What is Urinary incontinence?

Urinary incontinence (inability to control the flow of urine and involuntary urination) is found to be associated with 1,632 drugs and 2,518 conditions by eHealthMe. Check the latest studies of Urinary incontinence.



On Aug, 11, 2026

11 people who have Antiinflammatory Therapy and Urinary Incontinence are studied.

Would you have Urinary incontinence when you have Antiinflammatory therapy?

Gender of people who have Antiinflammatory Therapy and experienced Urinary Incontinence *:

  • female: 70 %
  • male: 30 %

Age of people who have Antiinflammatory Therapy and experienced Urinary Incontinence *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 22.22 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 77.78 %

Common co-existing conditions for these people *:

  1. Sleep Disorder: 5 people, 45.45%
  2. High Blood Pressure: 5 people, 45.45%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 36.36%
  4. Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 3 people, 27.27%
  5. Memory Loss: 3 people, 27.27%
  6. Eye Disorder: 3 people, 27.27%
  7. Bone Disorder: 2 people, 18.18%
  8. High Blood Cholesterol: 2 people, 18.18%
  9. Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 18.18%
  10. Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 1 person, 9.09%

Common drugs taken by these people *:

  1. Humira: 4 people, 36.36%
  2. Zolpidem: 3 people, 27.27%
  3. Naproxen: 3 people, 27.27%
  4. Deflazacort: 3 people, 27.27%
  5. Risperidone: 3 people, 27.27%
  6. Duloxetine Hydrochloride: 3 people, 27.27%
  7. Clonazepam: 3 people, 27.27%
  8. Timolol Maleate: 3 people, 27.27%
  9. Fluoxetine Hydrochloride: 3 people, 27.27%
  10. Alendronate Sodium: 3 people, 27.27%

Common symptoms for these people *:

  1. Pain: 4 people, 36.36%
  2. Fall: 4 people, 36.36%
  3. Visual Impairment: 4 people, 36.36%
  4. Joint Pain: 4 people, 36.36%
  5. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 27.27%
  6. Pulmonary Oedema (fluid accumulation in the lungs): 3 people, 27.27%
  7. Mobility Decreased (ability to move is reduced): 3 people, 27.27%
  8. Femur Fracture: 3 people, 27.27%
  9. Memory Loss: 3 people, 27.27%
  10. Labyrinthitis (inflammation of the labyrinth or inner ear): 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Urinary incontinence?

- Check whether Urinary incontinence is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Urinary incontinence:

All the conditions that are associated with Urinary incontinence:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Urinary incontinence and Antiinflammatory therapy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: